EcoDrugPlus

Granzyme B(G,h)

Ensembl ID : ENSORLG00000024404
Gene Symbol: SI:CH211-212D10.1
3 Cross references
969 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSORLG00000016626
Gene Symbol: GHRHR
4 Cross references
191 Possible Orthologues:

Growth Hormone Secretagogue Receptor A

Ensembl ID : ENSORLG00000011709
Gene Symbol: GHSRA
4 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSORLG00000019522
Gene Symbol: FABP2
3 Cross references
210 Possible Orthologues:

Guanylate Cyclase 1, Soluble, Alpha 2

Ensembl ID : ENSORLG00000010515
Gene Symbol: GUCY1A2
3 Cross references
202 Possible Orthologues:

Heat Shock Protein 90, Alpha (Cytosolic), Class A Member 1, Tandem Duplicate 2

Ensembl ID : ENSORLG00000025267
Gene Symbol: HSP90AA1.2
4 Cross references
345 Possible Orthologues:

Heat Shock Protein 90, Alpha (Cytosolic), Class B Member 1

Ensembl ID : ENSORLG00000022434
Gene Symbol: HSP90AB1
4 Cross references
339 Possible Orthologues:

High Mobility Group Box 1a

Ensembl ID : ENSORLG00000003400
Gene Symbol: HMGB1A
3 Cross references
511 Possible Orthologues:

High Mobility Group Box 1b

Ensembl ID : ENSORLG00000003951
Gene Symbol: HMGB1B
4 Cross references
509 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSORLG00000004554
Gene Symbol: HRH1
4 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSORLG00000010128
Gene Symbol: HRH2
4 Cross references
182 Possible Orthologues:

Histamine Receptor H2a

Ensembl ID : ENSORLG00000003959
Gene Symbol: HRH2A
4 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).